H100 Group (H100) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
18 May, 2026Executive summary
Operating income rose to 3.1 MSEK in Q1 2026 from 2.9 MSEK year-over-year, while operating loss widened to -145.9 MSEK due to significant non-cash items related to bitcoin holdings and FX effects.
Strategic acquisitions, including Future Holdings AG and a pending deal for Moonshot AS and Never Say Die AS, are set to increase bitcoin holdings from 1,051 BTC to approximately 3,500 BTC, establishing a strong operational base in Switzerland and expanding European presence.
The capital structure remains simple, with no warrants or exotic instruments, and only about 220 MSEK in convertible debt, supported by a much larger bitcoin treasury post-acquisition.
Health technology operations continue to develop, with the launch of a scalable group coaching product in April 2026.
Financial highlights
Operating income: 3.1 MSEK (Q1 2026) vs. 2.9 MSEK (Q1 2025).
Operating loss (EBIT): -145.9 MSEK (Q1 2026) vs. -3.0 MSEK (Q1 2025), with 138.6 MSEK from non-cash items.
Loss before tax: -155.4 MSEK (Q1 2026) vs. -3.1 MSEK (Q1 2025), with 148.1 MSEK non-cash.
Loss per share: -0.46 SEK (Q1 2026) vs. -0.03 SEK (Q1 2025).
Cash flow for the period: -7.7 MSEK (Q1 2026) vs. 14.8 MSEK (Q1 2025).
Equity ratio: 88% (Q1 2026) vs. 30% (Q1 2025).
Outlook and guidance
Post-acquisition, the group expects to operate with approximately 3,500 BTC, low debt, and a strong presence in Switzerland and the Nordics.
The company aims to grow bitcoin per share, scale profitable business, and become the leading listed bitcoin platform in Europe.
Latest events from H100 Group
- Strategic shift to Bitcoin treasury drove rapid asset growth but resulted in large non-cash losses.H100
H2 25/2624 Feb 2026 - Scalable health tech platform leverages influencer networks for rapid, recurring global growth.H100
Status Update23 Nov 2025 - Accelerating Bitcoin Treasury and global health initiatives to empower sovereign individuals.H100
Status Update21 Nov 2025 - Strong sales growth and Bitcoin accumulation, but significant non-cash losses and volatility.H100
H1 25/2619 Nov 2025 - Revenue up 166%, net loss reduced, and strategic shift to digital health acquisition underway.H100
H1 24/2513 Jun 2025 - Annual loss deepened on portfolio write-downs; net asset value per share fell 22%.H100
H2 23/2413 Jun 2025 - Acquisition-driven transformation and capital infusion position H100 for digital health growth.H100
H2 24/2511 Jun 2025